. "2014"^^ . "none"@en . . "1365287-97-3" . . . "48"^^ . "MO4K3GDN1I" . . . "LY2875358"@en . . . "2120"^^ . "none"@en . . . "981873210"^^ . . . . . . "MO4K3GDN1I"@en . . . "46624714"^^ . . . . "mab"@en . . "6356"^^ . . "zu/o"@en . "1694"^^ . . "1365287"^^ . . "9810"^^ . "Emibetuzumab (INN) (LY2875358) is a humanized monoclonal antibody designed for the treatment of cancer. It is in phase II trials for patients with NSCLC This drug was developed by Eli Lilly & Company."@en . . "7748"^^ . "Emibetuzumab (INN) (LY2875358) is a humanized monoclonal antibody designed for the treatment of cancer. It is in phase II trials for patients with NSCLC This drug was developed by Eli Lilly & Company."@en . "Emibetuzumab"@en .